|
| Press Releases |
|
 |
|
| Friday, May 27, 2022 |
|
|
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products |
| On April 26, 2022, the expedition ship Xuelong 2 for China's 38th Antarctic expedition berthed at the Shanghai base dock. So far, China's 38th Antarctic expedition, which lasted 174 days and traveled more than 33,000 nautical miles, has ended successfully. more info >> |
|
| Wednesday, April 27, 2022 |
|
|
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis |
| Legend Capital's portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage M201 program from Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and other viral diseases. more info >> |
|
| Tuesday, April 26, 2022 |
|
|
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022 |
| Legend Capital's portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for initial public offering (IPO) on the KOSDAQ market, and it plans to submit a registration statement within the second quarter of 2022. more info >> |
|
| Sunday, April 24, 2022 |
|
|
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床 |
| 君联资本联合创建企业朗信生物（Innostellar Biotherapeutics Co.,Ltd）旗下上海朗昇生物科技有限公司宣布，公司产品LX101注射液用于治疗RPE65双等位基因突变相关的遗传性视网膜变性（IRD）患者的临床试验申请，已获得中国国家药品监督管理局药品审评中心（CDE）批准。 more info >> |
|
|
君聯資本聯合創建企業朗信生物遺傳性視網膜變性基因治療產品在中國獲批臨床 |
| 君聯資本聯合創建企業朗信生物（Innostellar Biotherapeutics Co.,Ltd）旗下上海朗昇生物科技有限公司宣佈，公司產品LX101注射液用於治療RPE65雙等位基因突變相關的遺傳性視網膜變性（IRD）患者的臨床試驗申請，已獲得中國國家藥品監督管理局藥品審評中心（CDE）批准。 more info >> |
|
|
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China |
| Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital's co-founded company Innostellar Biotherapeutics more info >> |
|
| Thursday, April 7, 2022 |
|
|
君联资本所投创新型疫苗领军企业瑞科生物在港交所成功上市 |
| 3月31日，君联资本所投创新型疫苗领军企业瑞科生物（股票代码：02179.HK）在港交所成功上市。此次在港上市，成为“香港HPV疫苗第一股”、“香港新型佐剂疫苗第一股”的瑞科生物相信将会给香港资本市场注入新的活力。 more info >> |
|
|
君聯資本所投創新型疫苗領軍企業瑞科生物在港交所成功上市 |
3月31日，君聯資本所投創新型疫苗領軍企業瑞科生物（股票代碼：02179.HK）在港交所成功上市。此次在港上市，成為「香港HPV疫苗第一股」、「香港新型佐劑疫苗第一股」的瑞科生物相信將會給香港資本市場注入新的活力。
more info >> |
|
|
Legend Capital's Portfolio Company Recbio Lists on HKEX Successfully |
| On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. more info >> |
|
| Tuesday, March 8, 2022 |
|
|
从边缘走向舞台中央：君联资本所投生物技术产业链上游专精特新企业的奋斗之路 |
| 据联想控股微空间报导，「专精特新」的灵魂是创新，强调「专精特新」就是要鼓励创新。政策目标在于强化科技创新和产业链供应链韧性，加强基础研究，推动应用研究，开展补链强链专项行动，加快解决「卡脖子」难题。联想控股旗下君联资本不仅有幸参与到众多「专精特新」企业的发展中，也践行着将「前瞻性」及「硬科技」作为关键词的投资理念。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Graphene Manufacturing Group Graphene Aluminium-Ion Battery: Collaboration with World Leading USA Battery Innovation Centre and Next Steps Toward Commercialisation
Mar 4, 2025 17:12 HKT/SGT
|
|
|
General Atomics Acquires North Point Defense
Mar 4, 2025 17:02 HKT/SGT
|
|
|
Nissin Foods (Hong Kong) Charity Fund Supporting Talents in Food and Nutritional Sciences for the Third Consecutive Year
Mar 4, 2025 16:54 HKT/SGT
|
|
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Mar 4, 2025 16:53 HKT/SGT
|
|
|
重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據 療效顯著 多重代謝獲益 市場前景廣闊
Mar 4, 2025 16:39 HKT/SGT
|
|
|
曹操智行自动驾驶平台上线 构建国内首个"F立方"全域自研闭环智驾生态
Mar 4, 2025 16:35 HKT/SGT
|
|
|
日清食品（香港）慈善基金連續三年支持食品及營養科學人才
Mar 4, 2025 16:15 HKT/SGT
|
|
|
曹操智行自動駕駛平台上線 構建國內首個"F立方"全域自研閉環智駕生態
Mar 4, 2025 16:11 HKT/SGT
|
|
|
歷史性全球反詐騙峰會在倫敦召開，共同打擊日益猖獗的網路詐騙
Mar 4, 2025 16:00 HKT/SGT
|
|
|
历史性全球反诈骗峰会在伦敦召开，共同打击日益猖獗的网络诈骗
Mar 4, 2025 16:00 HKT/SGT
|
|
|
Historic Global Anti-Scam Summit Convenes in London to Combat Escalating Online Fraud
Mar 4, 2025 16:00 HKT/SGT
|
|
|
プライドワン・エンタテインメント、戦後８０年の節目の終戦映画構想を発表
Mar 4, 2025 15:00: JST
|
|
|
Prideone Entertainment announces concept for post-war film to mark 80th anniversary of the end of World War II
Mar 4, 2025 16:00 JST
|
|
|
穆罕默德·本·扎耶德人工智慧大學（MBZUAI）推出首個同類本科人工智慧課程，協助未來AI領袖成長
Mar 4, 2025 14:00 HKT/SGT
|
|
|
穆罕默德·本·扎耶德人工智能大学（MBZUAI）推出首个同类本科人工智能课程，助力未来AI领袖成长
Mar 4, 2025 14:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
